WHO Committee Wants Biosimilars Added To Pre-Qualification

 
• By Aidan Fry

As biosimilars are added to the WHO’s list of essential drugs, an expert committee wants the global body to expand its pre-qualification program to cover more biosimilars.

WHO
The WHO should expand biosimilar pre-qualification and examine interchangeability, its expert committee says • Source: Shutterstock

More from Biosimilars

More from Products